Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · IEX Real-Time Price · USD
17.33
-0.05 (-0.29%)
Apr 19, 2024, 4:00 PM EDT - Market closed
Avadel Pharmaceuticals Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for AVDL stock have an average target of 23, with a low estimate of 16 and a high estimate of 29. The average target predicts an increase of 32.72% from the current stock price of 17.33.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AVDL stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 4 | 5 | 5 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 6 | 7 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +26.95% | Apr 9, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $20 → $22 | Strong Buy | Maintains | $20 → $22 | +26.95% | Mar 5, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $18 → $23 | Buy | Maintains | $18 → $23 | +32.72% | Mar 5, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $27 → $29 | Buy | Maintains | $27 → $29 | +67.34% | Mar 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $21 → $25 | Strong Buy | Maintains | $21 → $25 | +44.26% | Mar 5, 2024 |
Financial Forecast
Revenue This Year
165.42M
from 27.96M
Increased by 491.57%
Revenue Next Year
297.74M
from 165.42M
Increased by 79.99%
EPS This Year
-0.41
from -2.00
EPS Next Year
1.04
from -0.41
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 185.6M | 350.9M | 456.0M | 465.5M | 499.3M |
| Avg | 165.4M | 297.7M | 389.7M | 421.5M | 485.0M |
| Low | 143.6M | 235.2M | 297.9M | 375.1M | 466.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 563.9% | 112.1% | 53.2% | 19.4% | 18.5% |
| Avg | 491.6% | 80.0% | 30.9% | 8.2% | 15.1% |
| Low | 413.4% | 42.2% | 0.1% | -3.7% | 10.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.05 | 2.57 | 2.73 | 2.89 | 1.94 |
| Avg | -0.41 | 1.04 | 1.65 | 2.15 | 1.89 |
| Low | -1.00 | 0.25 | 0.82 | 1.48 | 1.81 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 163.5% | 74.7% | -9.9% |
| Avg | - | - | 59.5% | 30.4% | -12.4% |
| Low | - | - | -20.5% | -10.4% | -15.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.